Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant

Fc engineering is a promising approach to enhance the antitumor efficacy of monoclonal antibodies (mAbs) through antibody-dependent cell-mediated cytotoxicity (ADCC). Glyco- and protein-Fc engineering have been employed to enhance FcγR binding and ADCC activity of mAbs; the drawbacks of previous app...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mimoto, Futa, Igawa, Tomoyuki, Kuramochi, Taichi, Katada, Hitoshi, Kadono, Shojiro, Kamikawa, Takayuki, Shida-Kawazoe, Meiri, Hattori, Kunihiro
Format:	Artigo
Language:	Inglês
Published:	Landes Bioscience 2013
Subjects:	Report
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3893233/ https://ncbi.nlm.nih.gov/pubmed/23406628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.23452
Tags:	Add Tag No Tags, Be the first to tag this record!

Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant

Similar Items